SEK23.15
1.49% day before yesterday
Stockholm, Jun 28, 05:29 pm CET
ISIN
SE0009947534
Symbol
SEDANA
Sector

Sedana Medical Target price 2024 - Analyst rating & recommendation

Sedana Medical Classifications & Recommendation:

Buy
100%

Sedana Medical Target price

Target price SEK35.50
Course SEK23.15
Price potential
Number of estimates 2
2 Analysts have issued a price target Sedana Medical 2025 . The average Sedana Medical target price is SEK35.50. This is higher than the current share price. The highest price target is , the lowest is .
A rating was issued by 1 analysts: 1 Analysts recommend Sedana Medical to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the Sedana Medical share has an average upside potential 2025 of . Most analysts recommend the Sedana Medical share at Purchase.

Sales and margin forecast 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Million SEK 153.87 187.65
25.23% 21.95%
EBITDA margin -38.63% -25.31%
50.56% 34.48%
Net margin -38.74% -13.23%
35.25% 65.85%

2 Analysts have issued a sales forecast Sedana Medical 2024 . The average Sedana Medical sales estimate is

SEK188m
unlock
. This is
13.79% higher
unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
SEK188m 14.18%
unlock
, the lowest is
SEK187m 13.40%
unlock
.

This results in the following potential growth figures:

Sales forecast

2023 SEK154m 25.23%
2024
SEK188m 21.95%
unlock
2025
SEK240m 27.74%
unlock
2026
SEK383m 59.68%
unlock
2027
SEK702m 83.41%
unlock

2 Analysts have issued an Sedana Medical EBITDA forecast 2024. The average Sedana Medical EBITDA estimate is

SEK-47.5m
unlock
. This is
31.62% lower
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
SEK-29.0m 19.65%
unlock
, the lowest is
SEK-66.0m 82.88%
unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 SEK-59.4m 38.09%
2024
SEK-47.5m 20.09%
unlock
2025
SEK-23.0m 51.58%
unlock
2026
SEK37.5m 263.04%
unlock
2027
SEK171m 354.93%
unlock

EBITDA margin

2023 -38.63% 50.56%
2024
-25.31% 34.48%
unlock
2025
-9.60% 62.07%
unlock
2026
9.80% 202.08%
unlock
2027
24.30% 147.96%
unlock

1 Analyst has issued a net profit forecast Sedana Medical 2024 . The average Sedana Medical net profit estimate is

SEK-24.8m
unlock
. This is
8.72% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
SEK-24.8m 8.72%
unlock
, the lowest is
SEK-24.8m 8.72%
unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 SEK-59.6m 18.92%
2024
SEK-24.8m 58.32%
unlock
2025
SEK-56.6m 127.94%
unlock
2026
SEK5.0m 108.78%
unlock

Net margin

2023 -38.74% 35.25%
2024
-13.23% 65.85%
unlock
2025
-23.62% 78.53%
unlock
2026
1.30% 105.50%
unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share SEK -0.60 -0.25
18.92% 58.33%
P/E ratio negative
EV/Sales 10.35

1 Analysts have issued a Sedana Medical forecast for earnings per share. The average Sedana Medical <a href=/blog/eps>EPS is

SEK-0.25
unlock
. This is
8.70% lower
unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
SEK-0.25 8.70%
unlock
, the lowest is
SEK-0.25 8.70%
unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 SEK-0.60 18.92%
2024
SEK-0.25 58.33%
unlock
2025
SEK-0.57 128.00%
unlock
2026
SEK0.05 108.77%
unlock

P/E ratio

Current -100.74 254.72%
2024
-92.60 8.08%
unlock
2025
-40.61 56.14%
unlock
2026
463.00 1,240.11%
unlock

Based on analysts' sales estimates for 2024, the Sedana Medical share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

10.35
unlock
and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of
12.26
unlock
.

This results in the following potential growth figures and future valuations:

EV/Sales

Current 11.78 32.65%
2024
10.35 12.10%
unlock
2025
8.11 21.72%
unlock
2026
5.08 37.37%
unlock
2027
2.77 45.48%
unlock

P/S ratio

Current 13.94 36.15%
2024
12.26 12.12%
unlock
2025
9.59 21.71%
unlock
2026
6.01 37.37%
unlock
2027
3.28 45.48%
unlock

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now